Kaplan–Meier survival analysis showed that glioma patients with elevated ISG20 expression presented with unfavorable OS (P < 0.001, HR = 4.73, 95% CI: 3.67–6.11; Fig. 4A). This evidence concerns the gene ISG20 and glioma.